Clinical Trials Directory

Trials / Conditions / Thrombocytosis

Thrombocytosis

8 registered clinical trials studyying Thrombocytosis — 1 currently recruiting.

StatusTrialSponsorPhase
UnknownPredictors of Reactive Thrombocytosis in Critically Ill Septic Patients
NCT03531515
Sanjay Gandhi Postgraduate Institute of Medical Sciences—
CompletedRetrospective Data Collection of Routine Use With Spectra Optia® for Platelet Depletions
NCT02308787
Terumo BCT—
CompletedA Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow D
NCT02125318
Galena Biopharma, Inc.Phase 2
CompletedA Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF
NCT01787552
Novartis PharmaceuticalsPhase 1 / Phase 2
CompletedOpen Label Ruxolitinib (INCB018424) in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thromb
NCT00509899
Incyte CorporationPhase 1 / Phase 2
TerminatedFerinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD)
NCT00882414
Vifor PharmaPhase 2
RecruitingMolecular Biology of Polycythemia and Thrombocytosis
NCT00722527
University of Utah—
CompletedThe Role of Reactive Thrombocytosis in Children With Pneumococcal Infection
NCT01194349
Taipei Medical University WanFang Hospital—